Institut Esthederm AGE PROTEOM ADVANCED SERUM

The NAOS laboratories developed a patented biotechnology for Institut Esthederm and formulated the first cell longevity serum capable of targeting the root cause of skin aging, in particular the carbonylation of proteins, the most severe form of oxidation. AGE PROTEOM^TM Advanced Serum, protects and strengthens the cutaneous proteome.

Offering excellent tolerance, the AGE PROTEOM^TM Advanced Serum should be recommended from the age of 30 as a means to prevent and correct all signs of aging – alone or in addition to an anti-aging cream - or to maximise the efficacy of all aesthetic procedures aimed at preventing and correcting signs of aging.

Its clinical efficacy was demonstrated by a 6-month placebo-controlled study with application on one half of the face. After 28 days, the skin aged half as quickly on the side treated with AGE PROTEOM^TM Advanced Serum as on the side treated with the placebo. Its efficacy increased from month to month in terms of all signs of aging, especially skin quality, as perceived by over 90% of patients⁽³⁾.

AGE PROTEOM^TM Advanced Serum targets the root cause of skin aging, in particular the carbonylation of proteins, the most severe form of oxidation.

Clinically proven efficacy against all aging parameters⁽¹⁾ :

• Wrinkles -26%
• Loss of radiance -47%
• Uneven complexion -32%
• Sagging -28%
• Loss of density -24%

After 28 days, the skin ages at half the normal pace⁽²⁾

(1) Clinical test (scoring), 55 volunteers aged 42 to 65, stressful lifestyle, showing signs of fatigue & pigmentation disorders. Twice-daily application (morning & evening) for 6 months. Randomized application onto one half of the face: on one side Age Proteom™ + neutral cream (treated area), on the other neutral cream alone (control area).

(2) Average improvement in the 5 signs of aging after 1 month, versus a placebo with no biological effects after 2 months – clinical study, 6 months, 55 volunteers.